Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03192995 · ClinicalTrials.gov registry record · Phase 2
Treatment With Lorcaserin for Cocaine Use: The TLC Study
A Phase 2 study, sponsored by Glenn-Milo Santos.
- Terminated
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT03192995 is a Phase 2 study that was terminated before completion, run by Glenn-Milo Santos. The registered enrollment target is 22 participants.
The verdict
NCT03192995, a Phase 2 study, was terminated before completion, sponsored by Glenn-Milo Santos.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
This project is a placebo-controlled, double-blind randomized trial evaluating the feasibility, tolerability, acceptability and adherence for lorcaserin among actively using, men who have sex with men (MSM) with cocaine use disorders.The study will enroll 45 individuals who will randomly be assigned to either the treatment (lorcaserin) arm or the placebo arm, to be taken twice a day for 12 weeks.
Interventions
- DRUG Placebo Oral Tablet
- BEHAVIORAL ACASI
- DRUG lorcaserin
- BEHAVIORAL Substance use counseling
- DIAGNOSTIC_TEST Cocaine metabolites
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2020-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03192995
The ClinicalTrials.gov registry entry for NCT03192995 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glenn-Milo Santos, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo Oral Tablet is the first listed.
NCT03192995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03192995 about?
NCT03192995 is a clinical study titled "Treatment With Lorcaserin for Cocaine Use: The TLC Study". This project is a placebo-controlled, double-blind randomized trial evaluating the feasibility, tolerability, acceptability and adherence for lorcaserin among actively using, men who have sex with men (MSM) with cocaine use disorders.The study will enroll 45 individuals who will randomly be assigned...
What is the current status of trial NCT03192995?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2018-01-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03192995?
The interventions under investigation include: Placebo Oral Tablet (DRUG), ACASI (BEHAVIORAL), lorcaserin (DRUG), Substance use counseling (BEHAVIORAL), Cocaine metabolites (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03192995?
This trial is sponsored by Glenn-Milo Santos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.